Related references
Note: Only part of the references are listed.Targeted therapy for nonsmall cell lung cancer: focusing on angiogenesis, the epidermal growth factor receptor and multikinase inhibitors
Elias A. Kotteas et al.
ANTI-CANCER DRUGS (2010)
The Role of Anti-Epidermal Growth Factor Receptor and Anti-Vascular Endothelial Growth Factor Therapies in the Treatment of Non-Small-Cell Lung Cancer
Corey Langer et al.
CLINICAL LUNG CANCER (2010)
Emerging roles of RNA and RNA-binding protein network in cancer cells
Mee Young Kim et al.
BMB REPORTS (2009)
HuR is exported to the cytoplasm in oral cancer cells in a different manner from that of normal cells
H. Hasegawa et al.
BRITISH JOURNAL OF CANCER (2009)
Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model
M. Yashiro et al.
BRITISH JOURNAL OF CANCER (2009)
The Role of HuR in Gemcitabine Efficacy in Pancreatic Cancer: HuR Up-regulates the Expression of the Gemcitabine Metabolizing Enzyme Deoxycytidine Kinase
Christina L. Costantino et al.
CANCER RESEARCH (2009)
VEGFs and receptors involved in angiogenesis versus lymphangiogenesis
Marja Lohela et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Lymphangiogenesis and cancer metastasis
Viviane Mumprecht et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
The Expression of RNA-Binding Protein HuR in Non-Small Cell Lung Cancer Correlates with Vascular Endothelial Growth Factor-C Expression and Lymph Node Metastasis
Jun Wang et al.
ONCOLOGY (2009)
Cytoplasmic Expression of HuR is Related to Cyclooxygenase-2 Expression in Colon Cancer
Sung-Jig Lim et al.
CANCER RESEARCH AND TREATMENT (2009)
Expression of the Embryonic Lethal Abnormal Vision-like Protein HuR in Human Mesothelioma Association With Cyclooxygenase-2 and Prognosis
Daniela Stoppoloni et al.
CANCER (2008)
Diverse molecular functions of Hu proteins
M. N. Hinman et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients
Kyuichi Kadota et al.
EUROPEAN JOURNAL OF CANCER (2008)
AUF1 and HuR proteins stabilize interleukin-8 mRNA in human saliva
V. Palanisamy et al.
JOURNAL OF DENTAL RESEARCH (2008)
Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human meningiomas
Takahiro Sakuma et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Artemisinin inhibits tumor lymphangiogenesis by suppression of vascular endothelial growth factor C
Jun Wang et al.
PHARMACOLOGY (2008)
Double-stranded RNA-binding protein regulates vascular endothelial growth factor mRNA stability, translation, and breast cancer angiogenesis
Frank Vumbaca et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice
Gaelle Brideau et al.
CANCER RESEARCH (2007)
Prognostic role of HuR in hereditary breast cancer
Mira Heinonen et al.
CLINICAL CANCER RESEARCH (2007)
COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia
M. Farooqui et al.
BRITISH JOURNAL OF CANCER (2007)
Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis
Caname Iwata et al.
CANCER RESEARCH (2007)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Alan Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression
Johnson Rajasingh et al.
FASEB JOURNAL (2006)
Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis
LT Soumaoro et al.
DISEASES OF THE COLON & RECTUM (2006)
Multiple roles of COX-2 in tumor angiogenesis: A target for antiangiogenic therapy
S Gately et al.
SEMINARS IN ONCOLOGY (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
β-catenin inversely regulates vascular endothelial growth factor-D mRNA stability
M Orlandini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The RNA-binding protein HuR regulates the expression of cyclooxygenase-2
S Sengupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation
WG Wang et al.
EMBO JOURNAL (2000)
Share Paper
